|
 Lack of vaccination passport, testing threaten Japan's reopening
Japan's lack of a vaccination passport and limited testing capacity
is threatening ambitions to reopen the economy at a crucial year-end
period when restaurants earn up to a half of their annual revenue
and travel agencies are at their busiest.
This means businesses, wary of another pandemic wave through winter,
are not rehiring laid-off staff or ordering more supplies until they
know more about what the reopening scheme will look like and how
long they can stay open. In the absence of a unified database of
vaccinations, local authorities have been largely left to fend for
themselves, creating a patchwork of rules and compliance schemes.
Northern Chinese city in soft lockdown amid latest outbreak
China reported nine new domestically transmitted COVID-19 cases for
Oct. 18, the highest daily tally since the end of September, with a
northern border city enforcing a soft lockdown to contain
infections.
Erenhot city in the autonomous region of Inner Mongolia, adjacent to
Mongolia, advised its 76,000 residents on Monday not to step out of
their residential compounds unless for necessary matters. It has
reported a total of two local cases as of Tuesday morning since Oct.
13.
Latvia announces four weeks of lockdown as cases spike
Latvia announced a COVID-19 lockdown from Oct. 21 until Nov. 15 to
try to slow a spike in infections in one of the least vaccinated
European Union countries. Only 54% of Latvian adults have been fully
vaccinated, well below EU average of 74%, EU figures show.
Only essential manufacturing, construction and critical jobs will be
allowed to continue in person with a curfew in place from 8 p.m. to
5 a.m. The Latvian government cancelled most planned hospital
operations last week amid an increased need for beds and staff as
COVID-19 cases climb.
[to top of second column] |
 WHO says it 'cannot cut
corners' in approving India's Covaxin shot
The World Health Organization on Monday asked
for further data from India's Bharat Biotech to
consider the company's request for an
emergency-use listing for its COVID-19 shot,
saying the WHO could not "cut corners" in making
a decision. Without a WHO nod, the two-dose
Covaxin is unlikely to be accepted as a valid
vaccine around the world and would complicate
travel plans for tens of millions of Indians who
have taken it.
 Bharat Biotech,
which developed Covaxin with an Indian state research body, started
sharing data with the WHO from early July. The vaccine was given
emergency-use authorisation in India in January even before the
completion of a late-stage trial, which later found the shot to be
78% efficacious. One in three UK music jobs wiped
out by COVID, report says
The COVID-19 pandemic has wiped out one in three jobs in the UK
music industry, a trade body said on Tuesday, as it called for
government support to help the sector recover. UK Music called on
the government to introduce tax incentives and employment-boosting
measures, and to help musicians and crew deal with the paperwork and
extra costs involved in touring mainland Europe after Brexit.
It said it also wants a permanent reduction in the value-added tax
(VAT) rate on tickets and live music events, more funding and
support for music exports as well as funding for music education and
for the self-employed.
(Compiled by Karishma Singh)
[© 2021 Thomson Reuters. All rights
reserved.] Copyright 2021 Reuters. All rights reserved. This material may not be published,
broadcast, rewritten or redistributed.
Thompson Reuters is solely responsible for this content |
